CME director awarded 645 fully vested shares

Bitsberger Timothy S. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bitsberger Timothy S. reported acquisition or exercise transactions in this Form 4 filing.

CME Group Inc. director Timothy S. Bitsberger received a grant of 645 shares of Class A Common Stock valued at $225 per share. This was issued as part of the company’s annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.

Following this award, Bitsberger directly holds 11,766 shares of CME Group Class A Common Stock. The granted shares are fully vested and are not subject to any vesting conditions, meaning he has full ownership and control of them immediately.

Insider Trade Summary

Grant/Award: 645 shares

Grant/Award 1 txn

Insider Bitsberger Timothy S.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Class A	645	$225.00	$145K

Holdings After Transaction: Common Stock Class A — 11,766 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

Key Figures

Shares granted: 645 shares Grant reference price: $225.00 per share Shares held after grant: 11,766 shares

3 metrics

Shares granted 645 shares Fully vested Class A Common Stock grant to director

Grant reference price $225.00 per share Reported transaction price per share for the 645-share award

Shares held after grant 11,766 shares Total direct Class A Common Stock holdings following the transaction

Key Terms

annual equity compensation program, CME Group Director Stock Plan, Class A Common Stock, fully vested shares

4 terms

annual equity compensation program financial

"issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors"

CME Group Director Stock Plan financial

"for non-employee directors under the CME Group Director Stock Plan"

Class A Common Stock financial

"Represents a grant of fully vested shares of Class A Common Stock issued"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

fully vested shares financial

"Represents a grant of fully vested shares of Class A Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CME (CME) director Timothy S. Bitsberger report in this Form 4?

Timothy S. Bitsberger reported receiving 645 fully vested shares of CME Group Class A Common Stock. The shares were granted as part of the company’s annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.

Was the CME (CME) Form 4 transaction an open-market purchase or sale?

The Form 4 shows a grant or award, not an open-market trade. Bitsberger received 645 shares as equity compensation, coded as an acquisition (transaction code A), rather than buying or selling shares on the open market.

How many CME (CME) shares does Timothy S. Bitsberger hold after this grant?

After the reported grant, Bitsberger directly holds 11,766 shares of CME Group Class A Common Stock. This total reflects his position following the addition of 645 fully vested shares from the annual director equity compensation program.

Are the newly granted CME (CME) shares subject to vesting conditions?

The 645 granted shares are fully vested and carry no vesting conditions. According to the disclosure, they were issued under the CME Group Director Stock Plan as part of the annual equity compensation program for non-employee directors, giving immediate ownership.

What does transaction code A mean in the CME (CME) Form 4 filing?

Transaction code A indicates a grant, award, or other acquisition of securities. In this case, it reflects that Bitsberger received 645 shares of CME Group Class A Common Stock as equity compensation, rather than through a market purchase transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bitsberger Timothy S.

(Last) (First) (Middle)

20 S. WACKER DRIVE

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock Class A	06/25/2026		A(1)		645	A	$225	11,766	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

Remarks:

	/s/ Elizabeth Hensen, as Attorney-in-Fact for Timothy S. Bitsberger	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)